Condition 101 About Acral Dysostosis Dyserythropoiesis Syndrome

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Acral Dysostosis Dyserythropoiesis Syndrome

RR
Elite
Roberta R. Russo
Naples, IT
AI
Elite
Achille Iolascon
IT
IA
Elite
Immacolata Andolfo
Naples, IT
FM
Elite
Francesco Manna
Naples, IT
BR
Elite
Barbara E. Rosato
Naples, IT

Latest Advances On Acral Dysostosis Dyserythropoiesis Syndrome

  • Condition: Congenital Dyserythropoietic Anemia Type I
  • Journal: European journal of haematology
  • Treatment Used: Pegylated interferon ?2a therapy
  • Number of Patients: 7
  • Published —
The study researched the use of Pegylated interferon ?2a therapy in treating congenital dyserythropoietic anemia type I.
  • Condition: Severe hemosiderosis, disturbed BM microenvironment
  • Journal: Pediatric transplantation
  • Treatment Used: haploidentical bone marrow transplantation with PT-CY
  • Number of Patients: 1
  • Published —
This report describes the case of a twelve year old male with severe hemosiderosis, disturbed bone marrow (BM) microenvironment which lead to experience graft failures.

Clinical Trials For Acral Dysostosis Dyserythropoiesis Syndrome

Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 200
  • Start Date: February 23, 2017
French National Registry of Congenital Dyserythropoietic Anemia
Clinical Trial
  • Status: Recruiting
  • Participants: 10000
  • Start Date: July 2016
The Congenital Dyserythropoietic Anemia Registry (CDAR)